Boehringer Ingelheim
Qingmin Guo has extensive experience in the field of pharmacology and biostatistics, including a notable role as a Trial Clinical Pharmacologist at Boehringer Ingelheim from October 2016 to February 2022. Prior to this position, Qingmin served as a Pharmacokinetic Analyst III at Morehouse School of Medicine from March 2006 to December 2011 and held research-related roles as a Research Associate at Emory University and a Postdoctoral Fellow at the University of Iowa. Qingmin's academic credentials include a PhD in Pharmacology from Peking Union Medical College and a Master's degree in Biostatistics from Michigan State University.
This person is not in any teams
This person is not in any offices